607 Characteristics of individuals in the United States ineligible for ivacaftor and elexacaftor-tezacaftor-ivacaftor

D. Sanders, N. Hamblett, M. Rosenfeld,D. Polineni, E. Dasenbrook,R. Szczesniak,E. Cromwell

Journal of Cystic Fibrosis(2023)

引用 0|浏览5
暂无评分
关键词
individuals,states,elexacaftor-tezacaftor-ivacaftor
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要